未登录 分享 收藏
Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT) 内源性库欣综合征中米托坦的前瞻性研究（PROMPT） Nieman, Lynnette K.; Boscaro, Marco; Scaroni, Carla; Deutschbein, Timo; Mezosi, Emese; Driessens, Natacha; Georgescu, Carmen E.; Motyka, Marcin; Hubalewska-Dydejczyk, Alicja; Jarzab, Barbara; Maiter, Dominique; Reincke, Martin; Loli, Paola; Zampetti, Benedetta; Atmaca, Aysegul; Badiu, Corin; Beckers, Albert; Bolanowski, Marek; Cavagnini, Francesco; Unger, Nicole; Giordano, Roberta; Hanzu, Felicia Alexandra; Terzolo, Massimo; Nader, Myriam Bou; Sinaii, Ninet; Toke, Judit; Toth, Miklos 分享 收藏
Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years 波兰儿童分化型甲状腺癌临床表现的变化: 一项跨越45年的回顾性队列研究 Kropinska, Aleksandra; Ledwon, Aleksandra; Cieslik, Ewa Paliczka; Olczyk, Tomasz; Blewaska, Aleksandra; Krzempek, Marcela; Wilk, Agata; Cortez, Alexander; Czarniecka, Agnieszka; Jarzab, Barbara; Junak, Daria Handkiewicz 分享 收藏
Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF) Leboulleux, Sophie; Kapiteijn, Ellen; Litiere, Saskia; Schoffski, Patrick; Godbert, Yann; Rodien, Patrice; Jarzab, Barbara; Salvatore, Domenico; Zanetta, Sylvie; Capdevila, Jaume; Bastholt, Lars; de la Fouchardiere, Christelle; Lalami, Yassine; Bardet, Stephane; Cornelis, Frank; Dedecjus, Marek; Links, Thera; Sents, Ward; Schlumberger, Martin; Locati, D. Laura; Newbold, Katie 分享 收藏
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-RefractoryDifferentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study Capdevila, Jaume; Krajewska, Jolanta; Hernando, Jorge; Robinson, Bruce; Sherman, Steven I.; Jarzab, Barbara; Lin, Chia-Chi; Vaisman, Fernanda; Hoff, Ana O.; Hitre, Erika; Bowles, Daniel W.; Williamson, Denise; Levytskyy, Roman; Oliver, Jennifer; Keam, Bhumsuk; Brose, Marcia S. 分享 收藏
分享 收藏
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer Hadoux, J.; Elisei, R.; Brose, M. S.; Hoff, A. O.; Robinson, B. G.; Gao, M.; Jarzab, B.; Isaev, P.; Kopeckova, K.; Wadsley, J.; Fuehrer, D.; Keam, B.; Bardet, S.; Sherman, E. J.; Tahara, M.; Hu, M. I.; Singh, R.; Lin, Y.; Soldatenkova, V; Wright, J.; Lin, B.; Maeda, P.; Capdevila, J.; Wirth, L. J. 分享 收藏
Randomized phase III study of selpercatinib versus cabozantinib or vandetanib in advanced, kinase inhibitornaive, RET-mutant medullary thyroid cancer Hadoux, J.; Elisei, R.; Brose, M. S.; Hoff, A.; Robinson, B.; Gao, M.; Jarzab, B.; Isaev, P.; Kopeckova, K.; Wadsley, J.; Fuhrer, D.; Keam, B.; Sherman, E. J.; Tahara, M.; Hu, M. I.; Lin, Y.; Maeda, P.; Wirth, L. J.; Castillon, J. Capdevila 分享 收藏
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial 卡博替尼治疗先前治疗的放射性碘难治性分化型甲状腺癌: COSMIC-311 3期试验的更新结果 Brose, Marcia S.; Robinson, Bruce G.; Sherman, Steven, I; Jarzab, Barbara; Lin, Chia-Chi; Vaisman, Fernanda; Hoff, Ana O.; Hitre, Erika; Bowles, Daniel W.; Sen, Suvajit; Oliver, Jennifer W.; Banerjee, Kamalika; Keam, Bhumsuk; Capdevila, Jaume 分享 收藏
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy 在分化良好的神经内分泌肿瘤患者中，通过肽受体放射性核素治疗控制疾病后，生长抑素类似物没有明显的益处 Sygula, Aleksandra; Ledwon, Aleksandra; Hasse-Lazar, Kornelia; Jurecka-Lubieniecka, Beata; Michalik, Barbara; Paliczka-Cieslik, Ewa; Zeman, Marcin; Chmielik, Ewa; Sczasny, Monika; Jarzab, Barbara; Handkiewicz-Junak, Daria 分享 收藏
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer 一项随机、双盲、非劣效性研究，旨在评估卡博替尼片剂每日60毫克与卡博替尼胶囊每日140毫克在进展性转移性甲状腺髓样癌患者中的疗效。 Capdevila, Jaume; Klochikhin, Arkadiy; Leboulleux, Sophie; Isaev, Pavel; Badiu, Corin; Robinson, Bruce; Hughes, Brett G. M.; Keam, Bhumsuk; Parnis, Francis; Elisei, Rossella; Gajate, Pablo; Gan, Hui K.; Kapiteijn, Ellen; Locati, Laura; Mangeshkar, Milan; Faoro, Leonardo; Krajewska, Jolanta; Jarzab, Barbara 分享 收藏
分享 收藏
Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015 低危甲状腺乳头状癌的治疗策略-2011和2015之间的第一个单中心前瞻性非随机试验的长期结果 Czarniecka, Agnieszka; Zeman, Marcin; Wozniak, Grzegorz; Maciejewski, Adam; Stobiecka, Ewa; Chmielik, Ewa; Oczko-Wojciechowska, Malgorzata; Krajewska, Jolanta; Handkiewicz-Junak, Daria; Jarzab, Barbara 分享 收藏
Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who have progressed after prior VEGFR-targeted therapy: Updated results from the phase III COSMIC-311 trial and prespecified subgroup analyses by prior therapy Capdevila, J.; Robinson, B.; Sherman, S. I.; Jarzab, B.; Lin, C-C.; Vaisman, F.; Hoff, A. O.; Hitre, E.; Bowles, D. W.; Sen, S.; Patel, P.; Oliver, J.; Keam, B.; Brose, M. S. 分享 收藏
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer BRAF V600E状态可显著区分乳头状甲状腺癌的淋巴结转移相关死亡风险 Tao, Yubing; Wang, Fei; Shen, Xiaopei; Zhu, Guangwu; Liu, Rengyun; Viola, David; Elisei, Rossella; Puxeddu, Efisio; Fugazzola, Laura; Colombo, Carla; Jarzab, Barbara; Czarniecka, Agnieszka; Lam, Alfred K.; Mian, Caterina; Vianello, Federica; Yip, Linwah; Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar; O'Neill, Christine J.; Sywak, Mark S.; Clifton-Bligh, Roderick; Bendlova, Bela; Sykorova, Vlasta; Zhao, Shihua; Wang, Yangang; Xing, Mingzhao 分享 收藏
A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations 遗传性和散发性胰腺神经内分泌肿瘤患者的直接比较: 临床过程，预后因素和基因型-表型相关性的评估 Soczomski, Przemyslaw; Jurecka-Lubieniecka, Beata; Krzywon, Aleksandra; Cortez, Alexander Jorge; Zgliczynski, Stanislaw; Rogozik, Natalia; Oczko-Wojciechowska, Malgorzata; Pawlaczek, Agnieszka; Bednarczuk, Tomasz; Jarzab, Barbara 分享 收藏
Shared and unique metabolic features of the malignant and benign thyroid lesions determined with use of 1H HR MAS NMR spectroscopy 使用1h HR MAS NMR光谱确定的恶性和良性甲状腺病变的共同和独特的代谢特征 Skorupa, Agnieszka; Ciszek, Mateusz; Chmielik, Ewa; Boguszewicz, Lukasz; Oczko-Wojciechowska, Malgorzata; Kowalska, Malgorzata; Rusinek, Dagmara; Tyszkiewicz, Tomasz; Kluczewska-Galka, Aneta; Czarniecka, Agnieszka; Jarzab, Barbara; Sokol, Maria 分享 收藏
分享 收藏
Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes Kukulska, Aleksandra; Krajewska, Jolanta; Gawkowska, Marzena; Paliczka-Cieslik, Ewa; Handkiewicz-Junak, Daria; Kropinska, Aleksandra; Puch, Zbigniew; Olczyk, Tomasz; Roskosz, Jozef; Jarzab, Barbara 分享 收藏
Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer 肿瘤微环境对甲状腺乳头状癌基因表达谱的影响 Oczko-Wojciechowska, Malgorzata; Pfeifer, Aleksandra; Jarzab, Michal; Swierniak, Michal; Rusinek, Dagmara; Tyszkiewicz, Tomasz; Kowalska, Malgorzata; Chmielik, Ewa; Zembala-Nozynska, Ewa; Czarniecka, Agnieszka; Jarzab, Barbara; Krajewska, Jolanta 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
THYROID.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏